All news


Accord acts differently to plot a path towards further growth

James Burt, EVP EMENA and Paul Tredwell, VP Specialty Brands met with Aidan Fry from Generics Bulletin to talk about Accord’s continued rise across Europe in hospital and retail generics and their exciting new developments in added-value products, including biosimilars.

Click here to read the full article.

All news